- Home
- NKSH vs MXCT Comparison
NKSH vs MXCT Comparison
Compare NKSH & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- MXCT
- Stock Information
- Founded
- NKSH 1891
- MXCT 1999
- Country
- NKSH United States
- MXCT United States
- Employees
- NKSH N/A
- MXCT N/A
- Industry
- NKSH Major Banks
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NKSH Finance
- MXCT Health Care
- Exchange
- NKSH Nasdaq
- MXCT Nasdaq
- Market Cap
- NKSH 185.2M
- MXCT 159.9M
- IPO Year
- NKSH N/A
- MXCT 2021
- Fundamental
- Price
- NKSH $30.09
- MXCT $1.44
- Analyst Decision
- NKSH Strong Buy
- MXCT Buy
- Analyst Count
- NKSH 1
- MXCT 4
- Target Price
- NKSH $38.00
- MXCT $7.50
- AVG Volume (30 Days)
- NKSH 8.6K
- MXCT 577.6K
- Earning Date
- NKSH 10-23-2025
- MXCT 11-12-2025
- Dividend Yield
- NKSH 5.07%
- MXCT N/A
- EPS Growth
- NKSH 41.83
- MXCT N/A
- EPS
- NKSH 2.04
- MXCT N/A
- Revenue
- NKSH $51,980,000.00
- MXCT $35,754,000.00
- Revenue This Year
- NKSH $2.95
- MXCT N/A
- Revenue Next Year
- NKSH $9.97
- MXCT $14.72
- P/E Ratio
- NKSH $14.59
- MXCT N/A
- Revenue Growth
- NKSH 19.64
- MXCT N/A
- 52 Week Low
- NKSH $23.75
- MXCT $1.26
- 52 Week High
- NKSH $32.39
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- NKSH 58.05
- MXCT 41.28
- Support Level
- NKSH $27.00
- MXCT $1.37
- Resistance Level
- NKSH $29.23
- MXCT $1.71
- Average True Range (ATR)
- NKSH 0.73
- MXCT 0.11
- MACD
- NKSH 0.19
- MXCT -0.01
- Stochastic Oscillator
- NKSH 100.00
- MXCT 20.97
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.